Mesa Laboratories Stock Performance
| MLAB Stock | USD 88.99 4.25 4.56% |
On a scale of 0 to 100, Mesa Laboratories holds a performance score of 10. The company secures a Beta (Market Risk) of 1.28, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. Please check Mesa Laboratories' downside variance, kurtosis, and the relationship between the value at risk and expected short fall , to make a quick decision on whether Mesa Laboratories' current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Mesa Laboratories are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Mesa Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.45) | Five Day Return (2.33) | Year To Date Return 17.39 | Ten Year Return 9.66 | All Time Return 3 K |
Forward Dividend Yield 0.0069 | Payout Ratio | Forward Dividend Rate 0.64 | Dividend Date 2026-03-16 | Ex Dividend Date 2026-02-27 |
| Mesa Laboratories dividend paid on 15th of December 2025 | 12/15/2025 |
2 | This Colorado lab company is sending cash straight to its shareholders - Stock Titan | 01/07/2026 |
3 | What are Mesa Laboratories Inc.s earnings expectations - Earnings Trend Report Fast Entry High Yield Stock Tips - mfd.ru | 01/29/2026 |
4 | Mesa Labs Fiscal Q3 Earnings Snapshot | 02/03/2026 |
5 | Mesa Laboratories Quarterly Profit Return Tests Longstanding Bearish Loss Narratives | 02/04/2026 |
6 | Mesa Laboratories, Inc. MLAB Shares Bought by Diamond Hill Capital Management Inc. - MarketBeat | 02/09/2026 |
7 | Heres Why Conestoga Capital Advisors Sold Mesa Laboratories | 02/20/2026 |
| Begin Period Cash Flow | 28.2 M | |
| Total Cashflows From Investing Activities | -4.5 M |
Mesa Laboratories Relative Risk vs. Return Landscape
If you would invest 7,625 in Mesa Laboratories on December 3, 2025 and sell it today you would earn a total of 1,699 from holding Mesa Laboratories or generate 22.28% return on investment over 90 days. Mesa Laboratories is currently generating 0.3715% in daily expected returns and assumes 2.7158% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of stocks are less volatile than Mesa, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mesa Laboratories Target Price Odds to finish over Current Price
The tendency of Mesa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 88.99 | 90 days | 88.99 | about 21.27 |
Based on a normal probability distribution, the odds of Mesa Laboratories to move above the current price in 90 days from now is about 21.27 (This Mesa Laboratories probability density function shows the probability of Mesa Stock to fall within a particular range of prices over 90 days) .
Mesa Laboratories Price Density |
| Price |
Predictive Modules for Mesa Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mesa Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mesa Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mesa Laboratories is not an exception. The market had few large corrections towards the Mesa Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mesa Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mesa Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 1.28 | |
σ | Overall volatility | 6.01 | |
Ir | Information ratio | 0.09 |
Mesa Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mesa Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mesa Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 154.48 M. | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Heres Why Conestoga Capital Advisors Sold Mesa Laboratories |
Mesa Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mesa Stock often depends not only on the future outlook of the current and potential Mesa Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mesa Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.4 M | |
| Cash And Short Term Investments | 27.3 M |
Mesa Laboratories Fundamentals Growth
Mesa Stock prices reflect investors' perceptions of the future prospects and financial health of Mesa Laboratories, and Mesa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mesa Stock performance.
| Return On Equity | 0.0218 | ||||
| Return On Asset | 0.0247 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 667.19 M | ||||
| Shares Outstanding | 5.52 M | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 2.76 X | ||||
| Price To Sales | 2.08 X | ||||
| Revenue | 240.98 M | ||||
| Gross Profit | 154.48 M | ||||
| EBITDA | 42.35 M | ||||
| Net Income | (1.97 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 181.47 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 33.79 X | ||||
| Cash Flow From Operations | 46.81 M | ||||
| Earnings Per Share | 0.65 X | ||||
| Market Capitalization | 515.13 M | ||||
| Total Asset | 433.35 M | ||||
| Retained Earnings | (188.94 M) | ||||
| Working Capital | (61.28 M) | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
About Mesa Laboratories Performance
By analyzing Mesa Laboratories' fundamental ratios, stakeholders can gain valuable insights into Mesa Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mesa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mesa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 118.16 | 208.66 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Mesa Laboratories performance evaluation
Checking the ongoing alerts about Mesa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mesa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 154.48 M. | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Heres Why Conestoga Capital Advisors Sold Mesa Laboratories |
- Analyzing Mesa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mesa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Mesa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mesa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mesa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mesa Laboratories' stock. These opinions can provide insight into Mesa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |